DOCS vs VRSN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 22, 2026
DOCS
VRSN
Investment Advisor Scores
VRSN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DOCS | VRSN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 19.1571 | 28.6533 | DOCS |
| PEG Ratio | 0.5895 | 2.7734 | DOCS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 7.3% | 6.0% | DOCS |
| Earnings Growth | -51.9% | 7.7% | VRSN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 37.7/100 | 44.5/100 | VRSN |
| Profit Margin | 25.5% | 49.8% | VRSN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | VRSN |
Relative Price Performance (Last 90 Days)
Current Technical Phase
DOCS
MarkupPrice above SMA50, rising 50-day trend (6.3% over 20 days), RSI 58
VRSN
NeutralMixed signals - no dominant trend phase, RSI 51
Fundamentals Snapshot
| Metric | DOCS | VRSN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 15.6 | 26.2 |
| Trailing P/E | 30.5 | 29.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.9% | 0.9% |
| Operating Margin | 0.2% | 0.7% |
| EPS | 0.85 | 9.33 |
| Dividend Yield | — | 0.01% |